Skip to main content
Advanced Enzyme Technologies Limited logo

Advanced Enzyme Technologies Limited — Investor Relations & Filings

Ticker · ADVENZYMES ISIN · INE837H01020 LEI · 335800PWJRERMBTUUV90 BSE.NS Manufacturing
Open in API
Filings indexed 938 across all filing types
Latest filing 2025-02-27 Regulatory Filings
Country IN India
Listing BSE.NS ADVENZYMES

About Advanced Enzyme Technologies Limited

https://www.advancedenzymes.com/

Advanced Enzyme Technologies Limited is a research-driven company specializing in the development, manufacturing, and marketing of proprietary enzyme products and probiotics. The company operates across the entire enzyme value chain, from research and development to commercial-scale production. Its diverse portfolio serves multiple sectors, including human nutrition, animal nutrition, and industrial processing. Key applications encompass food and beverage production, dietary supplements, animal feed additives, and various industrial processes such as textiles, detergents, and pulp and paper manufacturing. With a focus on biotechnology and sustainable solutions, the firm leverages its extensive R&D capabilities to provide customized enzyme formulations. The company maintains a global footprint, supplying specialized biological solutions to a broad international client base.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the schedule of upcoming analyst and institutional investor meetings. It references compliance with the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015. The content is purely an announcement of meetings with investors and analysts, without any financial data, report, or detailed presentation attached. The document length is short (1953 characters), and it does not contain financial statements or detailed analysis. Therefore, it is not an investor presentation (IP) or an interim report (IR). It is an announcement related to investor meetings, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-02-27 English
Credit Rating
Regulatory Filings
2025-02-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of a conference call held on February 12, 2025, discussing the un-audited financial results for the quarter and nine months ended December 31, 2024. It includes detailed management commentary on financial performance, business highlights, segment contributions, subsidiary performance, and answers to investor questions. The presence of a full transcript with management discussion and Q&A clearly identifies this as a Call Transcript related to earnings. The document length is substantial (15,000 characters), and it contains the full text of the call, not just an announcement or summary. Therefore, the appropriate classification is Call Transcript (CT).
2025-02-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation letter under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the availability of the audio recording of a conference call discussing the un-audited financial results for the quarter and nine months ended December 31, 2024. It mentions that the transcript will be provided later. The document is short (1764 characters) and serves as a notification about the conference call recording, not the transcript or the financial results themselves. Therefore, it is an announcement related to a conference call, not the full transcript. According to the filing definitions, a full text transcript of a conference call is classified as Call Transcript (CT), but this document only announces the availability of the audio recording and future transcript. Hence, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and notification, not the actual transcript or report.
2025-02-12 English
Copy of Newspaper Publication
Regulatory Filings
2025-02-10 English
Integrated Filing- Financial
Regulatory Filings
2025-02-08 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.